FDA approves Zepbound® (tirzepatide) as the first and only …
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound ® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. 1 Zepbound may help adults with moderate-to-severe ...
Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity ...
INDIANAPOLIS, June 21, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced detailed results from the SURMOUNT-OSA phase 3 clinical trials evaluating tirzepatide injection (10 mg or 15 mg) for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, with and without positive airway pressure (PAP ...
Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep …
5 days ago · The FDA late Friday approved Lilly’s tirzepatide, brand name Zepbound, for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea ...
Dec 20, 2024 · The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for the condition.
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
5 days ago · Zepbound, which was first approved for weight management in November 2023, now offers new hope for those with obesity and obstructive sleep apnea, Eli Lilly reported.
The FDA just approved Eli Lilly's Zepbound for sleep apnea - Yahoo
Dec 20, 2024 · Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate...
Tirzepatide reduced sleep apnea severity by up to nearly two …
Apr 17, 2024 · Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10 mg or 15 mg) significantly reduced...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
5 days ago · Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday. Trials of the...
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Jun 21, 2024 · Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a...
Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea …
Dec 20, 2024 · Eli Lilly said the Food and Drug Administration approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. The company said Zepbound, or tirzepatide, is the first...